Patent · US Active

Crystalline forms of (S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazine-7-yl)ethyl)amino)pyrimidine-5-carbonitrile as inhibitors of phosphatidylinositol-3-kinase

US11584750B2 · kind B2 · utility

0Cited by

1References

22Claims

0Family size

Assignee

HUTCHISON MEDIPHARMA LIMITED · CN

Inventors

Zhenping Wu · Shanghai, CN
Wenji Li · Shanghai, CN
Ling FENG · Shanghai, CN

Key dates

Filing date	Apr 18, 2019
Grant date	Feb 21, 2023
Priority date	—
Expiry date	Aug 17, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention belongs to the pharmaceutical field, and provides crystalline forms, solvates and the crystalline forms thereof of the compound (S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazin-7-yl)ethyl)amino)pyrimidine-5-carbonitrile of the formula shown below, and the pharmaceutical compositions comprising the same as well as the methods of preparing the same and the use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.